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Tobacco control efforts have contributed to a substantial decline in smoking preva-lence in the United States (US) from ap-
proximately 40% in 1965 to 15.5% in 2016.1,2 
Passage of the Family Smoking Prevention and 
Tobacco Control Act (TCA) in 2009 expanded 
regulatory efforts to include implementation of 
pictorial health warnings on cigarette packages by 
the Food and Drug Administration (FDA). How-
ever, litigation brought by the tobacco industry3 
blocked implementation of 9 pictorial warning 
labels selected by the FDA.4 The FDA is support-
ing research to strengthen evidence that such labels 
reduce smoking initiation and promote quitting.5 
The US is playing “catch up” in this regard; 105 
countries have already implemented the use of pic-
torial health warnings.6 Research to date supports 
their effectiveness. Graphic warning labels (GWLs) 
on cigarette packages have been associated with 
increased perception of the health risks of smok-
ing,7 increased quit attempts,8-10 lower smoking in-
tentions and initiation among youth,11,12 decreases 
in smoking relapse,13 and decreases in smoking 
prevalence.8,14 In experimental studies, smokers ex-
posed to GWLs on cigarette packs for 4 weeks were 
significantly more likely than controls to make 
Barbara K. Campbell, Adjunct Associate Professor, Oregon Health and Science University/Portland State University School of Public Health, Port-
land, OR. Thao Le, Programmer Analyst, University of California San Francisco, Philip R. Lee Institute for Health Policy Studies, San Francisco, CA. 
Deborah Yip, Research Analyst, University of California San Francisco, Philip R. Lee Institute for Health Policy Studies, San Francisco, CA. Kayla 
B. Griffin, Undergraduate Student, Morgan State University, Baltimore, MD. Noah R. Gubner, Postdoctoral Fellow, University of California San 
Francisco, Philip R. Lee Institute for Health Policy Studies, San Francisco, CA. Joseph R. Guydish, Professor, University of California San Francisco, 
Philip R. Lee Institute for Health Policy Studies, San Francisco, CA. 
Correspondence Dr Campbell; drbarbaracampbell@earthlink.net
Sex Differences in Graphic Warning  
Label Ratings by Addictions Clients
Barbara K. Campbell, PhD
Thao Le, MPH
Deborah Yip, BA
Kayla B. Griffin
Noah R. Gubner, PhD
Joseph R. Guydish, PhD
Objectives: Research on sex differences in response to cigarette graphic warning labels (GWLs) 
has been limited despite tobacco-related health disparities for women. We examined whether 
women had stronger responses to certain labels than to others, whether this pattern differed 
from men’s, and whether there were overall sex ratings differences. Methods: Smokers (N = 881) 
in 24 addictions treatment programs rated 3 of 9 Food and Drug Administration-developed 
labels on credibility, message reactance, quit motivation, and negative emotions. Participants 
rated one label depicting a woman and/or baby, and 2 depicting tobacco-related disease or 
male images. Results: Women’s (N = 432) ratings of labels depicting women/babies versus other 
labels did not differ from men’s (N = 449) ratings. Women had higher ratings than men across all 
labels combined on credibility (p < .001), quit motivation (p = .007), and negative emotions (p < 
.001). Individual labels were analyzed for sex differences. Women’s ratings were higher on cred-
ibility for 3 of 9 labels, and on negative emotions for 7 of 9 labels. Conclusions: Female smokers 
in addictions treatment had generally stronger responses to GWLs than men, supporting GWL 
implementation in the United States to help close the sex gap in smoking cessation.
Key words: addictions treatment; sex differences; packaging; vulnerable populations; warning labels
Tob Regul Sci.™ 2019;5(1):3-14
DOI: https://doi.org/10.18001/TRS.5.1.1
Sex Differences in Graphic Warning Label Ratings by Addictions Clients
4
a quit attempt9 or to begin a smoking cessation 
intervention.15
Women experience significant health disparities 
related to smoking.16 Despite no overall sex dif-
ference in quit attempts, women have lower rates 
of successfully quitting17,18 and experience greater 
risk of certain health consequences of smoking 
than men (eg, coronary heart disease).19 There is 
a need for sex-focused study in all areas of tobacco 
research, including the study of GWLs, to identify 
interventions that improve smoking cessation rates 
among women.
Message segmentation strategies are health com-
munications intended to reach subpopulations by 
targeting group-relevant interests, concerns and 
experiences. They have shown promise in reducing 
health disparities, prompting recommendations to 
identify audience segments and target messages to 
those groups.20-22 Sex-based segmentation employing 
GWL images depicting harms of smoking to wom-
en, pregnant women and babies may be personally 
relevant for women, and thereby, more effective for 
them than for men or than other images. Research 
findings from general population samples generally 
support this hypothesis. We identified one study 
showing no sex differences23 and 4 in which women’s 
ratings of pregnancy or baby images differed from 
men’s ratings.24-27 In these studies, women rated the 
images higher in believability and motivation to quit 
or remain abstinent, as well as more effective in dis-
couraging smoking than men.24-27
Women with substance use disorders (SUDs), 
other than tobacco only, smoke at rates 3-4 times 
higher than the general population28 and have 
lower rates of successful cessation.17,18,29 They have 
been underserved regarding treatment of co-mor-
bid smoking and other substance use,30 while also 
being targeted by tobacco marketing,31,32 a com-
bination of factors supporting proposals for their 
designation as a tobacco use disparities group.16,33 
Developing effective tobacco control strategies 
for this vulnerable population is particularly im-
portant for increasing quit rates and reducing to-
bacco-related health disparities. Both regulatory 
efforts and targeted treatment interventions are 
likely needed to increase smoking cessation among 
women smokers with additional SUDs. Although 
study of GWLs within this population has just 
begun, initial evidence suggests GWLs have some 
positive behavioral impact. Smokers in residential 
SUD treatment who used GWL cigarette packs for 
30 days reported greater readiness to quit and were 
significantly more likely to attend a smoking cessa-
tion group session than those who used transparent 
label packs.15 The study did not report examina-
tion of sex differences. However, a qualitative study 
of GWL reactions among persons in addiction 
treatment did report sex-specific reactions, includ-
ing heightened responses by women to an image 
of a baby. The image evoked memories and nega-
tive feelings, indicative of its personal relevance for 
some female respondents.34 This finding, within a 
vulnerable, high-smoking group, corresponds with 
quantitative studies in the general population of 
smokers showing women’s heightened responses to 
images of babies relative to men’s responses.24-27
The current study examined ratings of GWLs 
by male and female smokers as part of a tobacco 
use and attitudes survey of adult clients in SUD 
treatment across the US. Based on prior studies, 
including the qualitative study findings of Pagano 
et al,34 we sought to identify potential sex-related 
differences in ratings of GWLs. Survey respondents 
viewed FDA-selected GWLs depicting a woman 
and/or a baby, tobacco-related disease, or male 
images. We examined whether women responded 
more strongly than men to images of women and/
or babies relative to their responses to other images 
on 4 measures assessing commonly used constructs 
in GWL ratings (credibility, message reactance, 
motivation to quit, and negative emotions). We 
then examined whether women responded differ-
ently than men overall on these measures. Thirdly, 
we examined whether women and men responded 
differently to individual GWLs.
METHODS
Sampling Design and Participants 
The survey was administered from March to No-
vember 2016 to 1153 participants enrolled in 24 
publicly funded, adult SUD treatment programs 
(10 residential/inpatient, 7 methadone main-
tenance, and 7 outpatient clinics) across the US 
providing treatment for individuals whose pri-
mary substance use disorder was not tobacco. All 
programs were affiliated with the National Drug 
Abuse Treatment Clinical Trials Network (CTN) 
(https://www.drugabuse.gov/about-nida/organi-
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zation/cctn/ctn/about-ctn), a national network of 
13 research centers and affiliated treatment pro-
grams, conducting community-based research to 
improve patient outcomes. Participating programs 
were randomly selected, stratified by program type 
(inpatient/residential, methadone maintenance, 
outpatient), from among 48 possible programs 
meeting inclusion criteria. Programs eligible for 
study participation were publicly funded, had 
a census of at least 60 active patients, and were 
willing to assign a staff study-liaison. Participat-
ing programs received a $2000 incentive following 
the survey site visit. All patients enrolled in treat-
ment for at least 10 days and present the day the 
survey was conducted were eligible to participate. 
The number of participants recruited from each 
clinic ranged from 32 to 55. Participants provided 
informed consent, completed surveys, and then 
received a $20.00 gift card. Details of sampling 
design, program selection and recruitment can be 
found in a previous paper.35
Procedure and Measures
Participants used iPads linked to a secure university 
server to complete self-administered surveys. Items 
used for the current analysis included demographic 
questions regarding age, sex (ie, female, male, other), 
race/ethnicity, marital status, employment status, 
and education. Respondents reported their primary 
drug and their smoking status. Current smoking was 
defined as reporting current smoking and lifetime 
smoking of at least 100 cigarettes. Each participant 
who identified as a current smoker viewed 3 GWLs 
from among the 9, FDA-selected GWLs presented 
in Figure 1. Labels included statements of negative 
health effects (addiction, disease causation, death, 
harm to children) and one positively framed mes-
sage (“Quitting smoking now greatly reduces serious 
risks to your health”), specified for inclusion by the 
TCA. Images depicted a woman and/or a baby, a 
man, or tobacco-related disease.
Each participant viewed one GWL randomly se-
lected from a subset of 3 depicting either a woman 
and/or baby (top of Figure 1) and 2 GWLs ran-
domly selected from the remaining subset depict-
ing a man or tobacco-related disease (bottom of 
Figure 1). The parent survey required about 40 
minutes to complete. We presented 3 GWLs rather 
than all 9 to each participant to manage the time 
burden of the full survey.
Participants were shown one label at a time and 
asked to rate it on 4 scales: credibility, message re-
actance, motivation to quit, and negative emotions. 
Each scale contained from 1 to 4 items. Items were 
rated using a 4-point Likert scale as has been done in 
other studies.22,36 Possible response options includ-
ed 1 = not at all, 2 = a little, 3 = somewhat, and 4 
= a lot. Participants could also select “I don’t know” 
on any item and could check “decline to answer” 
when rating negative emotions. “I don’t know” and 
“decline to answer” were recorded as missing values.
Credibility. This score was based on the mean of 
3 items: The label is informative, is based on facts, 
and increases my understanding of smoking risks. 
This measure was adapted from prior research on 
credibility as a mediator of effects of warning la-
bels on quit intentions and smoking-related out-
comes.36,37 Internal consistency for this measure 
was good (Cronbach’s α = .85).
Message reactance. Two items assessed clients’ 
tendency to react defensively to labels: “The label 
presented misleading information” and “The label 
exaggerates the health risks of smoking.” The 2 items 
were moderately correlated (r = .59) suggesting rea-
sonable internal consistency. We used the mean of 
the 2-items as the scale score. A low score on this 
measure indicated a positive response, (ie, label not 
perceived as misleading). This measure was modi-
fied from prior research,38 and is based on evidence 
of individuals’ attempts to reduce fear aroused by a 
message via dismissal, counterarguments, or avoid-
ance of fear-generating information.38-40
Motivation to quit. One item assessed motiva-
tion to quit (ie, “The label makes me want to quit 
smoking”). GWLs have been found to increase 
quit intentions,41 which in turn, have been associ-
ated with quit attempts42 and smoking cessation.43
Negative emotions. Participants rated each label 
(“Please tell us what you felt when looking at this 
label”) on 4 negative emotions: sad, angry, disgust-
ed, and guilty. The negative emotion score was the 
mean of the 4 emotions rated (Cronbach’s α = .91). 
This measure was based on a similar scale used in 
health communications research.44 Negative emo-
tions have been shown to mediate perceived risk, 
desire to smoke and quit intention responses to 
GWLs,36,37and have predicted reduced smoking 
satisfaction and lower cigarette consumption.45
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Data Analyses
The total sample included 1153 respondents. 
Some participants (N = 6) did not identify as either 
male or female, and some (N = 7) did not com-
plete GWL ratings. Of the remaining cases, 881 
(77.3%) identified as current smokers, including 
449 men and 432 women who comprised our sam-
ple. They smoked an average of 13.2 (SD = 8.47) 
cigarettes per day and began smoking on average at 
15.2 years old (SD = 4.47). They were compared 
on demographic variables (ie, age, race/ethnicity, 
education, marital status and employment status) 
and primary drug for which they entered treatment 
using a t-test for continuous variables and a chi-
square test for categorical variables to inform sub-
sequent analyses.
To evaluate whether women responded more 
strongly than men to GWLs depicting a woman 
and/or baby compared to other GWLs, we calcu-
lated the mean difference between ratings by label 
type (woman and/or baby vs all other labels) for 
women and men. Sex differences in the difference 
 
 
 
Figure 1
Nine FDA-approved Graphic Warning Labels
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scores were compared on each of the 4 measures 
(credibility, message reactance, motivation to quit, 
negative emotions) using t-tests.
Second, we examined whether there were any sex 
differences in ratings for all 9 GWLs combined to 
assess the more general question of whether men 
and women responded differently in overall ratings. 
We calculated a score for each participant on each 
measure (credibility, message reactance, motivation 
to quit, negative emotions) using the mean rating 
of the 3 GWLs each participant viewed. Linear 
mixed effects regression models with random inter-
cept were applied to assess the relationship between 
each measure and sex. Parameters were estimated 
using Restricted Maximum Likelihood (REML) 
method. These models controlled for variables that 
were statistically significant at a 0.10 alpha level in 
the univariate analysis by sex (ie, age, race/ethnic-
ity, education, marital status, and primary drug). 
Models also accounted for nesting of participants 
within clinic.
Last, we applied linear mixed effects regression 
models with random intercept to assess the rela-
tionships between each of the 3 measures that 
showed statistically significant overall sex differenc-
es (credibility, motivation to quit, negative emo-
Table 1
Demographics and Primary Drug Use for Female and Male Smokers in 
Substance Use Disorders Treatment
Variables Male (N = 449)
Female 
(N = 432)
Total 
(N = 881) p-value
Age 38.9 (11.85) 35.8 (10.53) 37.4 (11.32) < .001
Race/ethnicity    .028
    Hispanic 62 (13.8%) 50 (11.6%) 112 (12.7%)
    Non- Hispanic Black 82 (18.3%) 52 (12.0%) 134 (15.2%)
    Non- Hispanic White 243 (54.1%) 270 (62.5%) 513 (58.2%)
    Non- Hispanic Other 62 (13.8%) 60 (13.9%) 122 (13.8%)
Education < .001
    <HSa 108 (24.1%) 92 (21.4%) 200 (22.8%)
    HS/GEDa 194 (43.2%) 138 (32.1%) 332 (37.8%)
    >HS 147 (32.7%) 200 (46.5%) 347 (39.5%)
Marital status < .001
    Married 47 (10.5%) 56 (13.0%) 103 (11.7%)
    Divorced/Separated/Widowed 107 (23.8%) 129 (29.9%) 236 (26.8%)
    Not married but in long term relationship 96 (21.4%) 117 (27.1%) 213 (24.2%)
    Never married 199 (44.3%) 130 (30.1%) 329 (37.3%)
Employment status    .122
    Yes 132 (29.4%) 107 (24.8%) 239 (27.1%)
    No 317 (70.6%) 325 (75.2%) 642 (72.9%)
Primary drug of use    .005
    Alcohol 89 (19.8%) 74 (17.1%) 163 (18.5%)
    Stimulants 80 (17.8%) 120 (27.8%) 200 (22.7%)
    Opiates 226 (50.3%) 197 (45.6%) 423 (48.0%)
    Other 54 (12.0%) 41 (9.5%) 95 (10.8%)
Note.
a: HS refers to high school. GED refers to General Educational Development certificate.
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tions) and sex for each of 9 GWLs. These models 
also controlled for age, race/ethnicity, education, 
marital status, primary drug and accounted for 
nesting participants within clinic. We conducted 
27 comparison tests (9 labels over the 3 measures) 
and applied the False Discovery Rate procedure to 
control the possible Type I error rate inflation. Be-
cause the rate of missing data was low (3.5%), the 
multivariable models used complete case analysis. 
The total number of cases included in the models 
for overall measures (credibility, message reactance, 
motivation to quit, negative emotions) were 873, 
863, 876, 850, respectively. All analyses were con-
ducted using SAS version 9.3.
RESULTS
Comparison of Responses to GWLs of Women 
and/or Babies versus Other Labels by Sex
Table 1 shows the comparisons of demographic 
characteristics by sex. Male and female participants 
differed significantly on age, race/ethnicity, educa-
tion, marital status and primary drug; these were 
included as control variables in analyses of GWL 
ratings. In testing women’s difference scores (ie, rat-
ings of GWLs depicting women and/or babies vs 
other GWLs) compared to men’s difference scores, 
we found no sex-based differences on any of the 4 
measures. Table 2 shows these results.
Comparisons of Overall Responses to GWLs by 
Sex 
Table 3 summarizes the results of linear mixed 
effects regression models comparing the overall rat-
ings of GWLs by sex. The models adjusted for age, 
race/ethnicity, education, marital status, primary 
drug, and accounted for nesting participants with-
in clinic. Women had consistently higher ratings 
than men on 3 of the 4 ratings measures: credibility 
Table 2
Women’s and Men’s Difference Scores for Ratings of Women/Babies versus Other Labels
Women’s Difference Scores
(Ratings of Women/Babies vs 
Other Labels)
Men’s Difference Scores
 (Ratings of Women/Babies vs 
Other Labels)
p-value
Credibility -0.078 0.015 .089
Motivation to Quit -0.241 -0.206 .610
Message Reactance 0.053 0.058 .940
Negative Emotions -0.0004 -0.025 .630
Table 3
Comparisons of Overall Ratings of Graphic Warning Labels by Sex
Unadjusted Mean (SD) Adjusted Meana
Total Women Men
Adjusted Mean Difference 
(95%CI)
(Women vs Men)
p-value
Credibility 3.02 (0.76) 3.13 (0.71) 2.93 (0.78) 0.22 (0.12, 0.33) < .001
Motivation to Quit 2.55 (1.01) 2.63 (0.97) 2.46 (1.03) 0.21 (0.06, 0.35) .007
Message Reactance 1.95 (0.88) 1.89 (0.88) 2.01 (0.88) -0.06 (-0.18, 0.07) .359
Negative Emotions 2.52 (0.93) 2.70 (0.90) 2.34 (0.93) 0.38 (0.25, 0.52) < .001
Note.
a: Adjusted for age, race/ethnicity, education, marital status, primary drug use and controlling for nesting of participants
    within clinics.
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(adjusted mean ratings difference, women vs men 
= 0.22, 95% CI: 0.12, 0.33, p < .001), motivation 
to quit (adjusted mean ratings difference, women 
vs men = 0.21, 95% CI: 0.06, 0.35, p = .007), and 
negative emotions (adjusted mean ratings differ-
ence, women vs men = 0.38, 95% CI: 0.25, 0.52, 
p < .001). There was no difference between men 
and women on the message reactance measure (p 
= .359).
Comparisons of Responses to Each GWL by 
Sex
Table 4 presents results of comparisons by sex on 
each GWL for the ratings measures found signifi-
cant in the analysis of overall ratings (credibility, 
motivation to quit, negative emotions). All analyses 
adjusted for age, race/ethnicity, education, marital 
status, primary drug, and accounted for nesting par-
ticipants within clinic. There were statistically sig-
nificant sex differences on ratings of credibility and 
negative emotions for some GWLs; all differences 
on both measures were in the direction of women 
rating the labels more strongly. Women rated 3 of 
9 GWLs higher in credibility: “gum disease” (p < 
.009), “cadaver” (p = .009), and “stoma” (p = .019). 
Women rated 7 of 9 GWLs more strongly on nega-
tive emotions: “gum disease” (p = .014), “heart dis-
ease” (p= .041), “cadaver” (p = .011), “stoma” (p = 
.011), “incubator (baby)” (p = .009), “secondhand 
smoke (baby)” (p = .027), and “secondhand smoke 
(woman)” (p = .027). There were no statistically 
significant sex differences for any of the 9 GWLs 
on the motivation to quit measure.
DISCUSSION
Identifying effective GWLs for women, includ-
ing those in the high-smoking population of indi-
viduals with additional SUDs, may contribute to 
the reduction of tobacco-related, health disparities 
for women. In the present study, we found no dif-
ferences between male and female smokers in SUD 
treatment in ratings of images of women and/or ba-
bies versus other images. The research on responses 
to images of babies on GWLs in general samples of 
smokers is mixed; some have not shown sex-based 
differences,23 although others have shown women 
Table 4
Comparison of Ratings for Individual Graphic Warning Labels by Sex
Graphic 
Warning Label
Credibility Motivation to Quit Negative Emotions
Un-adjusted 
Mean (SD)
(Total)
Adjusted Mean 
Difference (95%CI)
(Women vs Men)a,b
Unadjusted 
Mean (SD)
(Total)
Adjusted Mean 
Difference (95%CI)
(Women vs Men)a
Unadjusted 
Mean (SD)
(Total)
Adjusted Mean 
Difference (95%CI)
(Women vs Men)a,b
Lung Disease 3.22 (0.86) 0.16 (-0.06, 0.38) 2.82 (1.14) 0.06 (-0.23, 0.36) 2.55 (1.07) 0.33 (0.04, 0.62)
Gum Disease 3.14 (0.85) 0.41 (0.20, 0.63)** 2.73 (1.19) 0.33 (0.01, 0.65) 2.57 (1.07) 0.46 (0.18, 0.73)*
Heart Disease 3.14 (0.88) 0.18 (-0.04, 0.40) 2.65 (1.18) 0.22 (-0.08, 0.53) 2.56 (1.09) 0.35 (0.08, 0.63)*
Cadaver 3.11 (0.94) 0.42 (0.19, 0.65)** 2.77 (1.22) 0.31 (0.01, 0.62) 2.69 (1.10) 0.47 (0.19, 0.74)*
Stoma 3.03 (0.87) 0.33 (0.11, 0.55)* 2.56 (1.21) 0.33 (0.02, 0.63) 2.50 (1.10) 0.47 (0.19, 0.74)*
Quit Guy 2.61 (1.02) -0.06 (-0.34, 0.21) 2.19 (1.16) -0.09 (-0.40, 0.22) 2.24 (1.13) 0.31 (0.00, 0.60)
Incubator 
(Baby) 3.17 (0.86) 0.13 (-0.09, 0.35) 2.44 (1.15) 0.23 (-0.08, 0.53) 2.61 (0.98) 0.45 (0.20, 0.71)**
Secondhand 
Smoke (Baby) 3.03 (0.87) 0.13 (-0.10, 0.36) 2.44 (1.17) 0.16 (-0.15, 0.47) 2.55 (0.98) 0.36 (0.10, 0.62)*
Secondhand 
Smoke 
(Woman)
2.82 (0.92) 0.15 (-0.09, 0.39) 2.28 (1.16) -0.15 (-0.45, 0.16) 2.34 (1.00) 0.36 (0.11, 0.61)*
*p < .05  **p < .01
Note.
a: Adjusted for age, race/ethnicity, education, marital status, primary drug use and controlling for nesting of participants within clinics
b: Controlled for multiple comparison tests by the False Discovery Rate procedure
Sex Differences in Graphic Warning Label Ratings by Addictions Clients
10
reporting personal relevance34 and rating the imag-
es more strongly than men.25,26,46 Numerous factors 
may contribute to different findings across studies, 
ranging from differences in participant samples (eg, 
smokers with SUDs vs general smoking samples) to 
variations in methods (eg, ratings measures, types 
of analyses conducted, such as comparisons of dif-
ference scores, as in our study).
Although women in our study did not respond 
differentially to images of women and/or babies 
versus other images relative to men’s responses, 
they did have generally stronger reactions to 
GWLs. Women rated the GWLs overall as more 
credible, evoking more negative emotions, and 
higher in motivation to quit. They also rated 3 
of 9 individual GWLs (ie, gum disease, cadaver, 
and person with a stoma) as more credible. These 
GWLs were 3 of the 4 labels rated highest in over-
all effectiveness according to Hammond et al.47 It 
may be that higher perceived credibility of these 
messages among women was associated with over-
all label effectiveness. Additionally, women rated 7 
of 9 GWLs higher in evoking negative emotions. 
The 2 labels with non-significant findings (lung 
disease, p = .074 and quit guy, p = .086) had the 
highest and lowest overall ratings respectively in 
our study, considering ratings of credibility, mo-
tivation to quit, and negative emotions, a finding 
also consistent with Hammond et al.47 It may be 
that sex differences in negative emotions ratings 
hold for the middle range of overall effectiveness, 
but fail when GWLs are either highly effective or 
highly ineffective. Findings of increased negative 
emotional responses by women to most of the 
GWLs may be important. Emotional responses to 
GWLs have been associated with quit intention, 
quit attempts and reduced cigarette consump-
tion.36,48 Women have lower rates of successful 
smoking cessation and face sex-specific barri-
ers to quitting ranging from fear of weight gain 
to more severe withdrawal symptoms.49 Women 
with SUDs face additional barriers to smoking 
cessation, including cultural (eg, high prevalence 
and acceptability of smoking,) and neurobiologi-
cal (eg, nicotine’s modulation of neurotransmit-
ter systems associated with rewarding effects of 
other substances).50,51 It is likely that an array of 
interventions, including tobacco-regulatory and 
treatment innovations, will be necessary to reduce 
the sex disparities in sustained smoking cessation. 
Early evidence suggests that GWL exposure on 
cigarette packs may influence quit behavior in 
the population of smokers in SUD treatment.15 
Prospective, sex-specific studies of GWLs that in-
clude smoking behavior outcomes are necessary 
to determine whether strong emotional reactions 
to GWLs facilitate smoking cessation among 
women.
There were no sex differences in overall message 
reactance ratings in our study. Research shows 
that perceived efficacy to respond to fear-arous-
ing messages is a variable which consistently af-
fects message reactance.52 We did not assess this in 
our study; thus, we cannot identify potential sex 
differences in perceived efficacy to address smok-
ing and whether this would inform our message 
reactance finding. It is possible that this special 
population of smokers with poor rates of success-
ful cessation53 have low perceived efficacy for ad-
dressing smoking regardless of sex. Future studies 
should examine the effect of self-efficacy promot-
ing messages accompanying GWLs, particularly in 
sub-populations of smokers with intractably low 
rates of cessation.52,54
Although women in our study had stronger 
overall ratings in motivation to quit, there were 
no sex differences on this measure for any individ-
ual GWL. A possible explanation is the decreased 
power available to detect differences associated 
with the smaller sample sizes for individual GWLs.
A growing body of research supports implemen-
tation of GWLs in the US.7,55,56 Our findings in-
dicate that GWLs with images of women, babies, 
and tobacco-related disease were impactful for 
women from a vulnerable population with high 
smoking rates and low rates of successful cessation. 
Findings support evidence that GWLs on cigarette 
packs are a population-level intervention that may 
be effective for diverse groups of smokers and may 
mitigate tobacco-related health disparities for 
women.57 Directions for future research regarding 
the effectiveness for GWLs for women, particularly 
women in high smoking, vulnerable populations, 
include conducting controlled trials in which (1) 
smokers are exposed over time to GWLs on ciga-
rette packages; (2) smoking, quit behavior, and 
sustained cessation outcomes are measured; and 
(3) outcomes are examined by sex, race/ethnicity, 
and co-morbidity with mental illness. Addition-
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Tob Regul Sci.™ 2019;5(1):3-14 11 DOI:   https://doi.org/10.18001/TRS.5.1.1
ally, research examining male versus female vari-
ants of specific GWL images (eg, depicting men vs 
women with tobacco-related disease) is necessary 
to determine whether sex of individuals depicted 
has differential sex-related effectiveness.
Limitations
Our study assessed sex differences in GWL rat-
ings in a large sample of smokers who were engaged 
in SUD treatment. Although we know of no a pri-
ori reason why smokers participating in SUD treat-
ment would respond differently to GWLs than 
other smokers, there may be group differences that 
affect responses to GWLs, thus limit generalizabil-
ity of our findings. Potential moderating variables 
such as health literacy or education levels may dif-
fer between smokers with SUDs and those in the 
general population. Additionally, given evidence of 
impulsivity and delay discounting,58 smokers with 
SUDs may be a group for whom anti-tobacco mes-
sages are less likely to facilitate behavior change 
despite immediate emotional reactions and quit 
motivation. Generalizability of results to other 
smokers with SUDs also may be limited. Partici-
pants in our sample of publicly funded programs 
within the CTN may differ from the population in 
for-profit treatment programs and programs out-
side the research network, as well as from the large 
number of individuals with SUDs who never ob-
tain treatment.
We did not have information regarding mental 
health diagnoses for our sample. SUDs and mental 
illness are often co-morbid conditions and individ-
uals in both groups smoke at higher rates than the 
general population.51 As such, the potential impact 
of GWLs on the population of individuals with co-
occurring disorders will be important to examine. 
We also did not ask participants whether they had 
children, an omission that precludes our ability to 
assess the potential relevance of women/baby im-
ages for parents versus non-parents or for mothers 
versus fathers. Given the public health significance 
of reducing smoking rates among pregnant women 
and mothers and given children of women with sub-
stance use disorders are already at increased risk for 
negative health consequences,59,60 this is an impor-
tant area of research for this population. A report in 
a general population sample suggests greater effec-
tiveness of such images for women of child-bearing 
age than for other women or for men.26
Our ratings measured constructs commonly 
used in GWL research, but which may not provide 
a comprehensive assessment of message impact.61 
The 4 measures of GWL responses likely co-vary; 
however, we examined them separately to facilitate 
interpretation. We were interested in the first order 
question of whether men and women may respond 
differently to FDA-selected GWL labels. Other 
possible relationships, for example, whether nega-
tive emotional responses mediate motivation to 
quit responses, were not examined. GWLs varied 
across multiple dimensions, such as style of graphic 
presentation (eg, comic book vs realistic) and nega-
tive versus positive message framing, which have 
been shown to affect responses to GWLs.25,47,62 
Our study did not identify whether these dimen-
sions may have contributed to our findings. It is 
possible that analyses of these dimensions would 
have informed our results regarding individual 
GWL ratings (eg, whether positive framing was 
a relevant variable in the non-significant, sex dif-
ference finding on negative emotion for the “quit” 
GWL). Finally, our participants rated GWLs based 
on a one-time exposure. We do not know whether 
findings generalize to real world conditions where 
smokers are regularly exposed to GWLs on ciga-
rette packages.
IMPLICATIONS FOR TOBACCO 
REGULATION
The FDA has sought to strengthen evidence that 
GWLs reduce smoking prevalence. This should 
include investigation of GWLs with specific sub-
populations who face tobacco-related disparities, 
such as women with additional SUDs, a group with 
high smoking rates resistant to smoking cessation. 
We found that female smokers in SUD treatment 
did not respond differentially to GWLs of women 
and/or babies but did rate GWLs more strongly 
overall than male smokers. Results support the use 
of graphic images including babies, women, and 
disease images, when developing warning labels for 
female smokers, including women with additional 
SUDs. Our findings contribute to the evidence 
base for implementation of GWLs on cigarette 
packaging in the US as one component of a com-
prehensive tobacco control policy that may reduce 
smoking cessation disparities.
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